US equities
|
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
MU
$1,029.00
▼-0.66%
NVDA
$229.28
▼-0.52%
SPCX
$162.57
▲+1.25%
TSLA
$382.70
▲+2.05%
AAPL
$336.64
▼-1.11%
MSFT
$535.07
▲+2.38%
AMZN
$262.43
▲+3.29%
META
$718.67
▼-0.31%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
PMGC Holdings Inc. - Common Stock
(NQ:
ELAB
)
3.080
-0.050 (-1.60%)
Delayed Quote
Updated: 3:53 PM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about PMGC Holdings Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update
October 08, 2026
Adoption of NorthStrive® brand marks and DBA registration establishes a unified identify across PMGC’s public holding company structure, with a formal legal name change expected within six months
From
PMGC Holdings Inc.
Via
GlobeNewswire
PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy
October 01, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs
September 29, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings
September 18, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
September 01, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio
August 26, 2026
Company prioritizes disciplined capital allocation while expanding machining capacity, integrating portfolio operations and evaluating robotics and automation to support organic growth
From
PMGC Holdings Inc.
Via
GlobeNewswire
PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss
August 25, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight
August 21, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
PMGC Holdings Inc. Announces Anticipated Reverse Stock Split
August 19, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q2 2026 Results and Files Form 10-Q; Total Assets Reach $36.6 Million, Up 184% from Year-End 2025 and 290% Year-over-Year, as Quarterly Revenue Nearly Doubles Sequentially
August 14, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
PMGC Holdings Confirms Compliance with Nasdaq’s New $5 Million Market Value of Listed Securities Requirement
July 29, 2026
Company Reports 8,095,835 Shares of Common Stock Issued and Outstanding as of July 29, 2026, and Moves to Correct Third-Party Market Data That Understates Its Current Share Count and Market...
From
PMGC Holdings Inc.
Via
GlobeNewswire
PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc.
July 28, 2026
Two-year renewable long-term agreement establishes A&B Aerospace as a precision manufacturing supplier to PAD Group and its subsidiaries across aerospace and defense programs. Agreement enables A&B...
From
PMGC Holdings Inc.
Via
GlobeNewswire
NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to License
July 27, 2026
Independent third-party validation will assess the patented technology’s software, architecture, and performance under controlled, simulation-based conditions
From
PMGC Holdings Inc.
Via
GlobeNewswire
NorthStrive Defense Tech Executes Definitive Exclusive License Agreement with Florida State University Research Foundation for Multi-Domain Drone Payload Technology Across Defense, Aerospace and Maritime Applications
July 13, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression
July 10, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
PMGC Holdings Inc. Announces Merger of AGA Precision Systems into A&B Aerospace
July 06, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences
July 01, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets
June 18, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
PMGC Holdings Highlights Advanced Precision Manufacturing Capabilities Supporting Space Exploration Supply Chains
June 10, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
NorthStrive Defense Tech Executes Binding Agreement to Acquire Exclusive License to Patented Multi-Domain Drone Payload Technology for Defense, Aerospace and Maritime Applications
June 08, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor Markets
June 01, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
GB Capital Ltd. Co-Advises on the Acquisition of A&B Aerospace Inc.
May 18, 2026
From
GB Capital Ltd.
Via
GlobeNewswire
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q1 2026 Results and Files Form 10-Q; Total Assets Reach Over $26.0 Million, Up 102% from Year-End 2025 and 193% Year-over-Year
May 15, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
PMGC Holdings (NASDAQ: ELAB) Acquires A&B Aerospace, Inc.
May 13, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions related to GLP-1 Use, Sarcopenia, Muscle Disuse Atrophy, and Certain Neurological Disorders
April 28, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans
April 28, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
NorthStrive Defense Tech Acquires Patented GPS-Denied Autonomous Drone Navigation Technology Option, Built for Defense and Counter-Unmanned Aircraft Systems
April 23, 2026
From
PMGC Holdings Inc.
Via
GlobeNewswire
SVM Machining, Inc. Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products Co., Inc.
April 21, 2026
Third Long-Term Agreement Signed by a PMGC Holdings Subsidiary in 2026, Reflecting Continued Growth in the Company’s Aerospace and Defense Supply Chain Presence
From
PMGC Holdings Inc.
Via
GlobeNewswire
PMGC Holdings, Inc. (Nasdaq: ELAB) Secures $40 Million Equity Purchase Facility Agreement: Announces Ability To Accelerate M&A Strategy Currently Focused on Acquiring Aerospace and Defense Manufacturing Companies
April 17, 2026
Approximately $10 Million To Be Funded at First Closing; 24-Month Commitment Period Provides Dedicated Capital to Execute on Active M&A Pipeline Currently focused on Aerospace, Defense, and Industrial...
From
PMGC Holdings Inc.
Via
GlobeNewswire
NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant Biosciences
April 13, 2026
Next-generation engineered probiotic targeting myostatin and Activin-A pathways advances toward clinical readiness across human and animal health applications
From
PMGC Holdings Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
